IBDEI0XE ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16571,0)
 ;;=535.50^^108^1044^5
 ;;^UTILITY(U,$J,358.3,16571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16571,1,3,0)
 ;;=3^535.50
 ;;^UTILITY(U,$J,358.3,16571,1,4,0)
 ;;=4^Gastr&Gastroduodenit w/o hem
 ;;^UTILITY(U,$J,358.3,16571,2)
 ;;=^270181
 ;;^UTILITY(U,$J,358.3,16572,0)
 ;;=790.5^^108^1044^10
 ;;^UTILITY(U,$J,358.3,16572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16572,1,3,0)
 ;;=3^790.5
 ;;^UTILITY(U,$J,358.3,16572,1,4,0)
 ;;=4^LFT Abnormal
 ;;^UTILITY(U,$J,358.3,16572,2)
 ;;=^273402
 ;;^UTILITY(U,$J,358.3,16573,0)
 ;;=592.0^^108^1045^5
 ;;^UTILITY(U,$J,358.3,16573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16573,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,16573,1,4,0)
 ;;=4^Kidney Stones
 ;;^UTILITY(U,$J,358.3,16573,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,16574,0)
 ;;=599.0^^108^1045^9
 ;;^UTILITY(U,$J,358.3,16574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16574,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,16574,1,4,0)
 ;;=4^Urinary Tract Infection
 ;;^UTILITY(U,$J,358.3,16574,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,16575,0)
 ;;=593.9^^108^1045^7
 ;;^UTILITY(U,$J,358.3,16575,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16575,1,3,0)
 ;;=3^593.9
 ;;^UTILITY(U,$J,358.3,16575,1,4,0)
 ;;=4^Renal Insufficiency
 ;;^UTILITY(U,$J,358.3,16575,2)
 ;;=^123849
 ;;^UTILITY(U,$J,358.3,16576,0)
 ;;=625.6^^108^1045^1
 ;;^UTILITY(U,$J,358.3,16576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16576,1,3,0)
 ;;=3^625.6
 ;;^UTILITY(U,$J,358.3,16576,1,4,0)
 ;;=4^Female Stress Incontinence
 ;;^UTILITY(U,$J,358.3,16576,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,16577,0)
 ;;=788.31^^108^1045^8
 ;;^UTILITY(U,$J,358.3,16577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16577,1,3,0)
 ;;=3^788.31
 ;;^UTILITY(U,$J,358.3,16577,1,4,0)
 ;;=4^Urge Incontinence
 ;;^UTILITY(U,$J,358.3,16577,2)
 ;;=^260046
 ;;^UTILITY(U,$J,358.3,16578,0)
 ;;=788.33^^108^1045^6
 ;;^UTILITY(U,$J,358.3,16578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16578,1,3,0)
 ;;=3^788.33
 ;;^UTILITY(U,$J,358.3,16578,1,4,0)
 ;;=4^Mixed Incontinence (M)(F)
 ;;^UTILITY(U,$J,358.3,16578,2)
 ;;=^293936
 ;;^UTILITY(U,$J,358.3,16579,0)
 ;;=599.70^^108^1045^2
 ;;^UTILITY(U,$J,358.3,16579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16579,1,3,0)
 ;;=3^599.70
 ;;^UTILITY(U,$J,358.3,16579,1,4,0)
 ;;=4^Hematuria NOS
 ;;^UTILITY(U,$J,358.3,16579,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,16580,0)
 ;;=599.71^^108^1045^3
 ;;^UTILITY(U,$J,358.3,16580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16580,1,3,0)
 ;;=3^599.71
 ;;^UTILITY(U,$J,358.3,16580,1,4,0)
 ;;=4^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,16580,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,16581,0)
 ;;=599.72^^108^1045^4
 ;;^UTILITY(U,$J,358.3,16581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16581,1,3,0)
 ;;=3^599.72
 ;;^UTILITY(U,$J,358.3,16581,1,4,0)
 ;;=4^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,16581,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,16582,0)
 ;;=795.00^^108^1046^4
 ;;^UTILITY(U,$J,358.3,16582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16582,1,3,0)
 ;;=3^795.00
 ;;^UTILITY(U,$J,358.3,16582,1,4,0)
 ;;=4^Abnormal Pap
 ;;^UTILITY(U,$J,358.3,16582,2)
 ;;=^328609
 ;;^UTILITY(U,$J,358.3,16583,0)
 ;;=626.8^^108^1046^30
 ;;^UTILITY(U,$J,358.3,16583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16583,1,3,0)
 ;;=3^626.8
 ;;^UTILITY(U,$J,358.3,16583,1,4,0)
 ;;=4^Dysfunctional Bleeding
 ;;^UTILITY(U,$J,358.3,16583,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,16584,0)
 ;;=628.9^^108^1046^44
 ;;^UTILITY(U,$J,358.3,16584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16584,1,3,0)
 ;;=3^628.9
 ;;^UTILITY(U,$J,358.3,16584,1,4,0)
 ;;=4^Female Infertility Nos
